NOTE PURCHASE
AGREEMENT


 


This Note Purchase
Agreement (this “Agreement”) is dated as of March 3, 2014, between Enerpulse Technologies, Inc., a Nevada corporation
(the “Company”), and each purchaser identified on the signature pages hereto (each, a “Purchaser”
and collectively, the “Purchasers”).


 


WHEREAS, subject
to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser,
and each Purchaser, severally and not jointly, desires to purchase from the Company, up to $400,000 of secured promissory notes
of the Company as more fully described in this Agreement.


 


NOW, THEREFORE,
in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:


 


ARTICLE I.

DEFINITIONS


 


1.1Definitions.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the
meanings set forth in this Section 1.1:


 


“Additional
Closing Date” means the date any Additional Closing occurs.


 


“Business
Day” means any day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized
or required by law to remain closed.


 


“Closing Date”
means the date of the Initial Closing or the Additional Closing, as applicable, which will be a Business Day.


 


“Commission”
means the United States Securities and Exchange Commission.


 


“Common Stock”
means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.


 


“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.


 


“Initial Closing
Date” means the date the Initial Closing occurs.


 


“Liens”
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.


 


“Note(s)”
means the Secured Promissory Notes issued to the Purchasers pursuant to this Agreement, in the form of Exhibit A attached
hereto.


 


“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.


 


“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.


 


“Security
Agreement” means the Security Agreement by and between the Company and the Purchasers, in the form of Exhibit B
attached hereto.


 






    	 



    	 



    

 


“Subscription
Amount” means, as to each Purchaser, the amount to be paid for the Notes purchased hereunder as specified for such Purchaser
on Schedule A, as amended in connection with each Closing, to this Agreement in United States dollars and in immediately
available funds.


 


“Subsidiary”
means any subsidiary of the Company.


 


“Transaction
Documents” means this Agreement, the Notes, the Security Agreement, all exhibits and schedules thereto and hereto and
any other documents or agreements executed in connection with the transactions contemplated hereunder.


 


ARTICLE II.

PURCHASE AND SALE


 


2.1Purchase
and Sale of Notes.


 


(a)Initial Closing.
Subject to the satisfaction (or waiver) of the conditions set forth in Sections 2.3 and 2.4 below, the Company shall issue and
sell to each Purchaser set forth on Schedule A hereto, and each such Purchaser, severally but not jointly, shall purchase
from the Company on the Initial Closing Date, a Note in the Subscription Amount set forth opposite such Purchaser’s name
on Schedule A (the “Initial Closing”).


 


(b)Additional
Closing. Subject to the satisfaction (or waiver) of the conditions set forth in Sections 2.3 and 2.4 below, the Company shall
issue and sell to each Purchaser set forth on Schedule A hereto (as amended to provide for the purchase by such Purchaser
of a Note on an Additional Closing Date) and each such Purchaser, severally but not jointly, shall purchase from the Company on
an Additional Closing Date, a Note in the Subscription Amount set forth opposite such Purchaser’s name on Schedule A
(the “Additional Closings”).


 


2.2Closing.
The Initial Closing and any Additional Closings are each referred to in this Agreement as a “Closing”.
On or before the applicable Closing Date, each Purchaser shall deliver to the Company, via wire transfer
or a certified check, immediately available funds equal to such Purchaser’s Subscription Amount, and the Company shall deliver
to each Purchaser its respective Note and the Company and each Purchaser shall deliver the other items set forth in Section 2.3
deliverable at the Closing. Each Closing shall occur at the offices of the Company located at 2451
Alamo Ave SE, Albuquerque, New Mexico 87106, or such other location as the parties shall mutually agree. 


 


2.3Deliveries.


 


(a)On or prior to
the each Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:


 


(i)this
Agreement duly executed by the Company;


 


(ii)a Note
for the Subscription Amount;


 


(iii)the
Security Agreement duly executed by the Company; and


 


(iv)such
other documents relating to the transactions contemplated by this Agreement as such Purchaser or its counsel may reasonably request.


 


(b)On or prior to
the each Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:


 


(i)this
Agreement duly executed by such Purchaser;


 


(ii)such
Purchaser’s Subscription Amount by wire transfer or certified check;


 






    	 



    	 



    

 


(iii)the
Security Agreement (or an accession thereto) duly executed by such Purchaser; and


 


(iv)such
other documents relating to the transactions contemplated by this Agreement as the Company or its counsel may reasonably request.


 


2.4Closing Conditions. 


 


(a)The obligations
of the Company hereunder in connection with each Closing are subject to the following conditions being met:


 


(i)the
accuracy in all material respects on such Closing Date of the representations and warranties of the Purchasers contained herein
(unless as of a specific date therein in which case they shall be accurate as of such date);


 


(ii)all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to such Closing Date shall have been
performed; and


 


(iii)the
delivery by each Purchaser of the items set forth in Section 2.3(b) of this Agreement.


 


(b)The respective
obligations of the Purchasers hereunder in connection with each Closing are subject to the following conditions being met:


 


(i)the
accuracy in all material respects when made and on such Closing Date of the representations and warranties of the Company contained
herein (unless as of a specific date therein);


 


(ii)all
obligations, covenants and agreements of the Company required to be performed at or prior to such Closing Date shall have been
performed; and


 


(iii)the
delivery by the Company of the items set forth in Section 2.3(a) of this Agreement.


 


ARTICLE III.

REPRESENTATIONS AND WARRANTIES


 


3.1Representations
and Warranties of the Company. The Company hereby makes the following representations and warranties to each Purchaser:


 


(a)Organization
and Qualification. The Company and each of its subsidiaries (the “Subsidiaries”) is an entity duly incorporated
or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization,
with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.
Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles
of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified
to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of
the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified
or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on
the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations,
assets, business or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material
adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction
Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and to the knowledge of the Company no proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power
and authority or qualification.


 






    	 



    	 



    

 


(b)Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of each of this Agreement and the other Transaction Documents by the Company and the consummation by
it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company
and no further action is required by the Company, the board of directors of the Company, or the Company’s stockholders in
connection herewith or therewith. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery
will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute
the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except: (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by
applicable law.


 


(c)No Conflicts.
The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party,
the issuance and sale of the Notes, and the consummation by it of the transactions contemplated hereby and thereby do not and will
not: (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation,
bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or
without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary
debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of
the Company or any Subsidiary is bound or affected, or (iii) conflict with or result in a violation of any law, rule, regulation,
order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary
is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a
Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be
expected to result in a Material Adverse Effect.


 


(d)Filings, Consents
and Approvals. No consent, approval, order or authorization of, or designation, registration, declaration or filing with, any
federal, state, local or provincial or other governmental authority or other Person on the part of the Company is required in connection
with the valid execution and delivery of the Transaction Documents, or the offer, or issuance of the Notes other than, if required,
filings or qualifications under applicable federal or state securities laws.


 


(e)SEC Reports;
Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required to be filed
by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred
to herein as the “SEC Reports”) on a timely basis or has received a valid extension of such time of filing and
has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates and subject to any amendments
thereto which have been filed prior to the date of this Agreement, the SEC Reports complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The Company has not, during the year preceding
the date hereof, been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included
in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the
Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company
and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods
then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.


 






    	 



    	 



    

 


3.2Representations
and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as
of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein):


 


(a)Organization;
Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability
company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and
performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary
corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction
Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with
the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance
with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.


 


(b)Own Account.
Such Purchaser understands that the Notes are “restricted securities” and have not been registered under the Securities
Act or any applicable state securities law and is acquiring its Note as principal for its own account and not with a view to or
for distributing or reselling such Note or any part thereof in violation of the Securities Act or any applicable state securities
law, has no present intention of distributing such Note in violation of the Securities Act or any applicable state securities law
and has no direct or indirect arrangement or understandings with any other Persons to distribute or regarding the distribution
of such Note in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting
such Purchaser’s right to sell the Note pursuant to a registration statement or otherwise in compliance with applicable federal
and state securities laws). Such Purchaser is not acquiring its Note as part of a group within the meaning of Section 13(d)(3)
of the Exchange Act.


 


(c)Experience
of Such Purchaser; Investigation. Such Purchaser (i) is an “accredited investor” as defined in Rule 501(a)(1),
(a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) either alone or together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective
purchase of the Notes, and has so evaluated the merits and risks of such purchase, including, without limitation, the risks identified
on Annex I attached hereto. Such Purchaser is able to bear the economic risk of a purchase of a Note and, at the present
time, is able to afford a complete loss of the purchase price of such Note. Such Purchaser in making its purchase decision has
relied solely upon an independent investigation made by such Purchaser and its legal, tax and/or financial advisors and, is not
relying upon any oral representations of the Company.


 


(d)Access to Information.  Such
Purchaser understands that a purchase of a Note involves a high degree of risk and illiquidity, including, risk of loss of the
entire purchase price of such Note.  Such Purchaser represents that such Purchaser has been given full and complete access
to the Company for the purpose of obtaining such information as such Purchaser or its qualified representative has reasonably requested
in connection with the decision to purchase the Note.  Such Purchaser represents that such Purchaser has received and
reviewed copies of the SEC Reports.  Such Purchaser represents that such Purchaser has been afforded the opportunity
to ask questions of the officers of the Company regarding its business prospects and the Notes, as such Purchaser has found necessary
to make an informed decision to purchase a Note.


 






    	 



    	 



    

 


(e)General Solicitation.
Such Purchaser is not purchasing the Note as a result of any advertisement, article, notice or other communication regarding the
Notes published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or
any other general solicitation or general advertisement.


 


(f)Information
Regarding Offering. No Person has made to the Purchaser any written or oral representations (i) that any Person will resell
or repurchase any Note; (ii) that any Person will refund the purchase price of any Note; (iii) as to the future value of the Note;
or (iv) that any Note will be listed and posted for trading on any stock exchange or automated dealer quotation system or that
application has been made to list and post any Note on any stock exchange or automated dealer quotation system;


 


(g)Restricted
Securities. Such Purchaser has been advised that none of the Notes have been registered under the Securities Act or any other
applicable securities laws, and that the Notes are being offered and sold pursuant to Section 4(a)(2) of the Securities Act and/or
Rule 506 of Regulation D thereunder, and that the Company’s reliance upon Section 4(a)(2) and/or Rule 506 of Regulation D
is predicated in part on such Purchaser representations as contained herein.


 


(h)Legal and Tax
Advice. Such Purchaser understands that nothing in the SEC Reports, this Agreement or any other materials presented to such
Purchaser in connection with a purchase of a Note constitutes legal, tax or investment advice. Such Purchaser has consulted such
legal, tax and investment advisors, as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase
of a Note.


 


(i)Disclosure.
Such Purchaser understands and confirms that the Company will rely on the foregoing representation in effecting transactions in
securities of the Company. All of the representations and warranties furnished by or on behalf of the Purchaser to the
Company in this Agreement are true and correct.


 


ARTICLE IV.

OTHER AGREEMENTS OF THE PARTIES


 


4.1Indemnification.


 


(a)Company’s Indemnification
of Purchasers. To the extent permitted by law, the Company shall defend, indemnify and hold harmless each of the Purchasers
from and against any and all losses, claims, judgments, liabilities, demands, charges, suits, penalties, costs or expenses, including
court costs and attorneys’ fees resulting from any claim, demand, suit, action or proceeding brought by any third party (“Claims
and Liabilities”) with respect to or arising from (i) the breach of any warranty or any inaccuracy of any representation
made by the Company in this Agreement or in the Security Agreement, or (ii) the breach of any covenant or agreement made by
the Company in this Agreement or the Security Agreement.


 


(b)Purchasers’ Indemnification
of Company. To the extent permitted by law, each of the Purchasers, severally but not jointly, shall defend, indemnify and
hold harmless the Company from and against any and all Claims and Liabilities with respect to or arising from (i) the breach
of any warranty or any inaccuracy of any representation made by such Purchaser in this Agreement, or (ii) the breach of any
covenant or agreement made by such Purchaser (A) in this Agreement and (B) in the event such Purchaser acts as the Collateral Agent
(as defined in the Security Agreement), in the Security Agreement.


 






    	 



    	 



    

 


(c)Claims Procedure. Promptly after
the receipt by any indemnified party (the “Indemnitee”) of notice of the commencement of any action or proceeding
against such Indemnitee, such Indemnitee shall, if a claim with respect thereto is or may be made against any indemnifying party
(the “Indemnifying Party”) pursuant to this Section 4.1, give such Indemnifying Party written notice of the
commencement of such action or proceeding and give such Indemnifying Party a copy of such claim and/or process and all legal pleadings
in connection therewith. The failure to give such notice shall not relieve any Indemnifying Party of any of its indemnification
obligations contained in this Section 4.1, except where, and solely to the extent that, such failure actually and materially prejudices
the rights of such Indemnifying Party. Such Indemnifying Party shall have, upon request within thirty (30) days after receipt of
such notice, but not in any event after the settlement or compromise of such claim, the right to defend, at its own expense and
by its own counsel reasonably acceptable to the Indemnitee, any such matter involving the asserted liability of the Indemnitee;
provided, however, that if the Indemnitee determines that there is a reasonable probability that a claim may materially and adversely
affect it, other than solely as a result of money payments required to be reimbursed in full by such Indemnifying Party under this
Section 4.1 or if a conflict of interest exists between Indemnitee and the Indemnifying Party, the Indemnitee shall have the right
to defend, compromise or settle such claim or suit; and, provided, further, that such settlement or compromise shall not, unless
consented to in writing by such Indemnifying Party, which shall not be unreasonably withheld, be conclusive as to the liability
of such Indemnifying Party to the Indemnitee. In any event, the Indemnitee, such Indemnifying Party and its counsel shall cooperate
in the defense against, or compromise of, any such asserted liability, and in cases where the Indemnifying Party shall have assumed
the defense, the Indemnitee shall have the right to participate in the defense of such asserted liability at the Indemnitee’s
own expense. In the event that such Indemnifying Party shall decline to participate in or assume the defense of such action, prior
to paying or settling any claim against which such Indemnifying Party is, or may be, obligated under this Section 4.1 to indemnify
an Indemnitee, the Indemnitee shall first supply such Indemnifying Party with a copy of a final court judgment or decree holding
the Indemnitee liable on such claim or, failing such judgment or decree, the terms and conditions of the settlement or compromise
of such claim. An Indemnitee’s failure to supply such final court judgment or decree or the terms and conditions of a settlement
or compromise to such Indemnifying Party shall not relieve such Indemnifying Party of any of its indemnification obligations contained
in this Section 4.1, except where, and solely to the extent that, such failure actually and materially prejudices the rights of
such Indemnifying Party. If the Indemnifying Party is defending the claim as set forth above, the Indemnifying Party shall have
the right to settle the claim only with the consent of the Indemnitee.


 


(d)Exclusive Remedy. Each of the
parties hereto acknowledges and agrees that, from and after each Closing Date, its sole and exclusive monetary remedy with respect
to any and all claims relating to the subject matter of this Agreement shall be pursuant to the indemnification provisions set
forth in this Section 4.1, except that nothing in this Agreement shall be deemed to constitute a waiver of any injunctive or other
equitable remedies or any tort claims of, or causes of action arising from, intentionally fraudulent misrepresentation, willful
breach or deceit.


 


4.2Acknowledgement of Security Agreement.
Any Purchaser who agrees in writing to become a party hereto covenants and agrees to also be bound by all of the obligations,
terms and conditions of a “Secured Party” applicable thereto under the Security Agreement as if such Purchaser has
executed the Security Agreement.


 


ARTICLE V.

MISCELLANEOUS


 


5.1Fees and
Expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement.


 


5.2Entire Agreement.
The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with
respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.


 


5.3Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City
time) on a Business Day, (b) the next Business Day after the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number set forth on the signature pages attached hereto on a day that is not a Business Day or later
than 5:30 p.m. (New York City time) on any Business Day, (c) the second (2nd) Business Day following the date of mailing,
if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is
required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.


 






    	 



    	 



    




 


5.4Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.


 


5.5Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
each Purchaser (other than by merger) except to an affiliate of the Company. No Purchaser may assign any or all of its rights under
this Agreement without the prior written consent of the Company except to an affiliated entity of such Purchaser.


 


5.6No Third-Party
Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.


 


5.7Governing
Law. This Agreement and all actions arising out of or in connection with this Agreement shall be governed by and construed
in accordance with the laws of the State of Delaware, without regard to the conflict of laws provisions of the State of Delaware
or of any other state.


 


5.8Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being
understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.


 


5.9Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.


 


5.10Replacement
of Notes. If any certificate or instrument evidencing any Notes is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu
of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the
Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Notes.


 


5.11Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of
the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation
the defense that a remedy at law would be adequate.


 


5.12Construction.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting
party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and
every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after
the date of this Agreement.


 






    	 



    	 



    

 


5.13WAIVER
OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. 


 


 


 


(Signature Pages Follow)


 




    	 



    	 



    

 


IN WITNESS WHEREOF,
the parties hereto have caused this Note Purchase Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.


 


 


	
        ENERPULSE TECHNOLOGIES,
        INC.

         

         
	Address for Notice:
	
        By: /s/ Joseph E. Gonnella_________________

              Name: Joseph E. Gonnella

              Title: Chief Executive Officer

         

        With a copy to (which shall not constitute notice):
	
        Enerpulse Technologies, Inc.

        2451 Alamo Ave SE

        Albuquerque, New Mexico 87106

        Fax: 505-842-6592

	
         

        Greenberg Traurig LLP

        1201 K Street, Suite 1100

        Sacramento, CA 95814

        Attn: Mark C. Lee, Esq.

         

         
	 


 


 


 


[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK


SIGNATURE PAGE FOR PURCHASER FOLLOWS]


 




    	 



    	 



    

 


[PURCHASER SIGNATURE PAGES TO ENERPULSE
TECHNOLOGIES, INC. NOTE PURCHASE AGREEMENT]


 


IN WITNESS WHEREOF,
the undersigned have caused this Note Purchase Agreement to be duly executed by their respective authorized signatories as of the
date first indicated above.


 


 


Name of Purchaser: John Novak


 


Signature of Authorized Signatory of
Purchaser: /s/ John Novak                                         


 


Name of Authorized Signatory: John Novak


 


Title of Authorized Signatory: Individual


 


Email Address of Authorized Signatory:
Jnovak@enerpulse.com


 


Facsimile Number of Authorized Signatory: (505) 842-6592


 


Address for Notice to Purchaser:


 


9405 Augusta Ave NE


 


Albuquerque, NM 87111


Address for Delivery of Note to Purchaser (if not same as address
for notice):


 


                                                                                               


 


                                                                                               


  




    	 



    	 



    

 


[PURCHASER SIGNATURE PAGES TO ENERPULSE
TECHNOLOGIES, INC. NOTE PURCHASE AGREEMENT]


 


IN WITNESS WHEREOF,
the undersigned have caused this Note Purchase Agreement to be duly executed by their respective authorized signatories as of the
date first indicated above.


 


 


Name of Purchaser: Stephen Marino


 


Signature of Authorized Signatory of
Purchaser: /s/ Stephen Marino                           


 


Name of Authorized Signatory: Stephen Marino


 


Title of Authorized Signatory: Individual


 


Email Address of Authorized Signatory:
Smarino@enerpulse.com


 


Facsimile Number of Authorized Signatory: (505) 842-6592


 


Address for Notice to Purchaser:


 


1624 La Cabra Dr SE


 


Albuquerque, NM 87123


Address for Delivery of Note to Purchaser (if not same as address
for notice):


 


                                                                                               


 


                                                                                               



  




    	 



    	 



    

 


SCHEDULE A


 


	Purchaser	Subscription Amount	EIN
	Stephen Marino	$50,000.00	 
	John Novak	$30,000.00	 
	 	 	 


  




    	 



    	 



    

 


Annex
I


 


Risk
Factors


 


The risks described below are the ones the Company believes
are the most important for the Purchaser to consider, although these risks are not the only ones that the Company faces. If events
anticipated by any of the following risks actually occur, the Company’s business, operating results or financial condition
could suffer and the trading price of the Company’s common stock could decline. As used below, “we,” “us”
and “our” refer to Enerpulse Technologies, Inc., which is also sometimes referred to as the “Company.”


 


Risks Relating to Our Business


 


We have a history of losses and may continue to incur
losses in the future.


 


We have a history of losses and may continue
to incur losses in the future, which could negatively impact the trading value of our common stock. Specifically, we expect to
sustain losses in the next few years due to expenses relating to research and development and testing activities incurred in the
development of the automotive OEM business. We may continue to incur operating losses in future periods. These losses may increase
and we may never achieve or sustain profitability on a quarterly or annual basis in the future for a variety of reasons, including
increased competition, decreased growth in the automotive industry and other factors described elsewhere in this “Risk Factors”
section.


 


Further, we may incur significant losses
in the future due to unforeseen expenses, difficulties, complications and delays and other unknown events. If we cannot continue
as a going concern, our stockholders may lose their entire investment.


 


We anticipate that our cash on hand will be insufficient
to fund our plan of operations for the next 12 months and if we are unable to raise additional capital, our business may fail and
stockholders may lose their entire investment.


 


As of September 30, 2013, we had cash and
cash equivalents of $1,105,991 which we believe will not be sufficient to meet our anticipated capital requirements for the next
twelve months. Specifically, we anticipate that our existing capital resources will enable us to continue operations through the
first quarter of 2014. If we fail to raise additional capital through the public offering of shares contemplated in our Form S-1/A,
obtain additional financing from other sources, including from sales revenues, loans or private investments, we may be required
to change our planned business strategies. If we are unable to obtain adequate financing, we may not be able to successfully develop
and market our products and services. As a result, we would need to curtail business operations, which would have a material negative
effect on operating results, the value of our outstanding stock is likely to fall, and our business may fail, causing our stockholders
to lose their entire investment.


 


Because we may never earn significant revenues from our
operations, our business may fail and investors may lose all of their investment in our Company.


 


We have a history of limited revenues from
operations. We have yet to generate positive earnings and there can be no assurance that we will ever operate profitably. If our
business plan is not successful and we are not able to operate profitably, then our stock may become worthless and investors may
lose all of their investment in our company.


 


Prior to achieving broad acceptance and distribution
for our products, we anticipate that we will incur increased operating expenses without realizing any significant revenues. We
therefore expect to incur significant losses into the foreseeable future. We recognize that if we are unable to generate significant
revenues from the sale of our products in the future, we will not be able to earn profits or continue operations. There is no history
upon which to base any assumption as to the likelihood that we will prove successful, and we can provide no assurance that we will
generate sufficient revenues or ever achieve profitability. If we are unsuccessful in addressing these risks, our business will
fail and investors may lose all of their investment in our company.


 






    	 



    	 



    

 


In the course of preparing our financial statements for
the years ended December 31, 2012 and 2011, material weaknesses in our internal control over financial reporting were noted. We
expect to incur extra costs in implementing measures to address such weaknesses. If we fail to maintain an effective system of
internal control over financial reporting, we may not be able to accurately report our financial results. As a result, current
and potential investors could lose confidence in our financial reporting, which could harm our business and have an adverse effect
on our stock price.


 


Pursuant to Section 404 of the Sarbanes-Oxley
Act of 2002, we are required to annually furnish a report by our management on our internal control over financial reporting. Such
report must contain, among other matters, an assessment by our principal executive officer and our principal financial officer
on the effectiveness of our internal control over financial reporting, including a statement as to whether or not our internal
control over financial reporting is effective as of the end of our fiscal year. This assessment must include disclosure of any
material weakness in our internal control over financial reporting identified by management. We have historically had a small internal
accounting and finance staff. This lack of adequate accounting resources has resulted in the identification of material weaknesses
in our internal controls over financial reporting. A “material weakness” is a deficiency, or a combination of deficiencies,
in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our financial
statements will not be prevented or detected on a timely basis.


 


In connection with the audit of our financial
statements for the years ended December 31, 2012 and 2011, our management team identified material weaknesses relating to (i) insufficient
systems, procedures, and accounting personnel in place to ensure effective segregation of duties, and (ii) lack of the appropriate
technical resources in place to properly evaluate non-routine, complex transactions in accordance with generally accepted accounting
principles. We have taken steps, including implementing a plan to improve the segregation of the duties of our accounting staff
and hiring additional internal staff and/or outside consultants experienced in financial reporting as well as in SEC reporting
requirements. In addition, we plan to continue to take additional steps to seek to remediate these material weaknesses. If we do
not successfully remediate the material weaknesses described above, or if other material weaknesses or other deficiencies arise
in the future, we may be unable to accurately report our financial results on a timely basis, which could cause our reported financial
results to be materially misstated and require restatement which could result in the loss of investor confidence and/or cause the
market price of our common stock to decline.


 


If we are unable to establish appropriate internal financial
reporting controls and procedures, it could cause us to fail to meet our reporting obligations, result in the restatement of our
financial statements, harm our operating results, subject us to regulatory scrutiny and sanction, cause investors to lose confidence
in our reported financial information and have a negative effect on the market price for shares of our common stock.


 


Effective internal controls are necessary
for us to provide reliable financial reports and effectively prevent fraud. We maintain a system of internal control over financial
reporting, which is defined as a process designed by, or under the supervision of, our principal executive officer and principal
financial officer, or persons performing similar functions, and effected by our board of directors, management and other personnel,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with accounting principles generally accepted in the United States of America.


 


As a public company, we will have significant
additional requirements for enhanced financial reporting and internal controls. We will be required to document and test our internal
control procedures in order to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002, which requires annual
management assessments of the effectiveness of our internal controls over financial reporting, and, if we become an accelerated
filer, a report by our independent registered public accounting firm would be required. The process of designing and implementing
effective internal controls is a continuous effort that requires us to anticipate and react to changes in our business and the
economic and regulatory environments and to expend significant resources to maintain a system of internal controls that is adequate
to satisfy our reporting obligations as a public company.


 


We cannot assure you that we will not identify
areas requiring improvement in our internal control over financial reporting. We cannot assure you that the measures we may take
to remediate any areas in need of improvement will be successful or that we will implement and maintain adequate controls over
our financial processes and reporting in the future as we continue our growth. If we are unable to establish appropriate internal
financial reporting controls and procedures, it could cause us to fail to meet our reporting obligations, result in the restatement
of our financial statements, harm our operating results, subject us to regulatory scrutiny and sanction, cause investors to lose
confidence in our reported financial information and have a negative effect on the market price for shares of our common stock.


 






    	 



    	 



    

 


Our future is dependent upon our ability to obtain financing.
If we do not obtain such financing, we may have to cease our activities and investors could lose their entire investment.


 


There is no assurance that we will operate
profitably or generate positive cash flow in the future. We will require additional financing in order to proceed with the manufacture
and distribution of our products, including our Pulstar® pulse plugs. We will also need more funds if the costs of the
development and operation of our existing technologies are greater than we have anticipated. We will also require additional financing
to sustain our business operations if we are not successful in increasing revenues. We may not be able to obtain financing on commercially
reasonable terms or terms that are acceptable to us when it is required, or at all. Our future is dependent upon our ability to
obtain financing. If we do not obtain such financing, our business could fail and investors could lose their entire investment.


 


If adequate funds are not available, we could
be forced to discontinue product development and reduce or forego attractive business opportunities. To the extent that we raise
additional funds by issuing equity securities, our stockholders may experience significant dilution. In addition, debt financing,
if available, may involve restrictive covenants. We may seek to access the public or private capital markets whenever conditions
are favorable, even if we do not have an immediate need for additional capital at that time. Our access to the financial markets
and the pricing and terms we receive in the financial markets could be adversely impacted by various factors, including changes
in financial markets and interest rates.


 


Our forecasts regarding the sufficiency of
our financial resources to support our current and planned operations are forward-looking statements and involve significant risks
and uncertainties, and actual results could vary as a result of a number of factors, including the factors discussed elsewhere
in this “Risk Factors” section. We have based this estimate on assumptions that may prove to be wrong, and we could
utilize our available capital resources sooner than we currently expect.


 


Our operating results may fluctuate due to factors that
are difficult to forecast and not within our control.


 


Our past operating results may not be accurate
indicators of future performance, and you should not rely on such results to predict our future performance. Our operating results
have fluctuated significantly in the past, and could fluctuate in the future. Factors that may contribute to fluctuations include:


 


	 	•	
        changes in aggregate capital spending, cyclicality and other
        economic conditions, or domestic and international demand in the industries we serve;

         

	 	•	
        our ability to effectively manage our working capital;

         

	 	•	
        our ability to satisfy consumer demands in a timely and cost-effective
        manner;

         

	 	•	
        pricing and availability of labor and materials;

         

	 	•	our inability to adjust certain fixed costs and expenses for changes in demand;
	 	•	
        shifts in geographic concentration of customers, supplies and
        labor pools; and

         

	 	•	
        seasonal fluctuations in demand and our revenue.

         



If we are unable to adequately control the costs associated
with operating our business, including our costs of sales and materials, our business, financial condition, operating results and
prospects will suffer.


 






    	 



    	 



    

 


If we are unable to maintain a sufficiently
low level of costs for designing, manufacturing, marketing, selling and distributing our products relative to their selling prices,
our operating results, gross margins, business and prospects could be materially and adversely impacted. We have made, and will
be required to continue to make, significant investments for the design and sales of our products and technologies. There
can be no assurances that our costs of producing and delivering our products will be less than the revenue we generate from sales
or that we will achieve our expected gross margins.


 


We may be required to incur substantial marketing
costs and expenses to promote our products. If we are unable to keep our operating costs aligned with the level of revenues we
generate, our operating results, business and prospects will be harmed.


 


We rely on independent distributors for a substantial
portion of our sales.


 


We rely upon sales made by or through non-affiliated
distributors to customers. Sales through distributors accounted for 92% of our net sales during 2012. The loss of, or business
disruption at, one or more of these distributors may harm our business. If we are required to obtain additional or alternative
distribution agreements or arrangements in the future, we cannot be certain that we will be able to do so on satisfactory terms
or in a timely manner. Our inability to enter into satisfactory distribution agreements may inhibit our ability to implement our
business plan or to establish markets necessary to expand the distribution of our products successfully.


 


We derive a significant portion of our revenue from a
few customers and the loss of one of these customers, or a reduction in their demand for our services, could adversely affect our
business, financial condition, results of operations and prospects.


 


Our customer base is highly concentrated.
One or a few customers have represented a substantial portion of our consolidated revenues and gross profits in any one year or
over a period of several consecutive years. Advance Auto Parts accounted for 28% and 29% of our total revenues in the years ended
2012 and 2011, respectively. AutoZone accounted for 14% and 14% of our total revenues in the years ended 2012 and 2011, respectively.
A limited number of customers may continue to comprise a substantial portion of our revenue for the foreseeable future. We could
lose business from a significant customer for a variety of reasons, including:


 


	 	•	
        the consolidation, merger or acquisition of an existing customer,
        resulting in a change in procurement strategies employed by the surviving entity that could reduce the amount of orders we receive;

         

	 	•	
        our performance on individual relationships with one or more
        significant customers are impaired due to another reason, which may cause us to lose future business with such customers and, as
        a result, our ability to generate income would be adversely impacted; and

         

	 	•	
        the strength of our professional reputation.

         



We do not have contracts in the aftermarket.
The customer business relationship is based on mutual benefits to both parties. Either party may terminate the relationship without
cause which could impair our business, financial condition, results of operations and prospects.


 


We may not be able to persuade potential customers of
the merits of our products and justify their costs to increase our sales.


 


Because of technology in our pulse plug products,
we have been, and will continue to be, required to educate potential customers and demonstrate that the merits of such products
justify the costs associated with such products. We have relied on, and will continue to rely on, automobile manufacturers and
manufacturers in other industries and their dealer networks to market our products. The success of any such relationship will depend
in part on the other party’s own competitive, marketing and strategic considerations, including the relative advantages of
alternative products being developed and/or marketed by any such party. There can be no assurance that we will be able to continue
to market our products successfully so as to generate meaningful product sales increases or to continue at existing sales volumes.


 


We depend on intellectual property and the failure to
protect our intellectual property could adversely affect our future growth and success.


 






    	 



    	 



    

 


We rely on patent, trademark, trade secret
protection, and confidentiality and other agreements with employees, customers, partners and others to protect our intellectual
property. Because of rapid technological developments in the automotive industry and the competitive nature of the market, the
patent position of any component manufacturer is subject to uncertainties and may involve complex legal and factual issues. Consequently,
although we own certain patents, and are currently processing several additional patent applications, we do not know whether any
patents will be issued from these pending or future patent applications or whether the scope of the issued patents is sufficiently
broad to protect our technologies or processes. There can be no assurance that others will not independently develop similar products
or will not design around any patents that have been or may be issued to us. The failure to obtain patents in certain foreign countries
may materially adversely affect our ability to compete effectively in those international markets.


 


Moreover, patent applications and issued
patents may be challenged or invalidated. We could incur substantial costs in prosecuting or defending patent infringement suits.
Furthermore, the laws of some foreign countries may not protect intellectual property rights to the same extent as do the laws
of the United States.


 


The patents protecting our proprietary technologies
expire after a period of time. Currently, our patents have expiration dates ranging from 2018 through 2029. If we are not successful
in protecting our proprietary technology, it could have a material adverse effect on our business, financial condition and results
of operations.


 


There can be no assurance that we will be
successful in protecting our proprietary rights. For example, from time to time we may become aware of competing technologies employed
by third parties that may be covered by one or more of our patents. In such situations, we may seek to grant licenses to such third
parties or seek to stop the infringement, including through the threat of legal action. There is no assurance that we would be
successful in negotiating a license agreement on favorable terms, if at all, or able to stop the infringement. Any infringement
upon our intellectual property rights could have an adverse effect on our ability to develop and sell commercially competitive
systems and components.


 


If third parties claim that our products infringe upon
their intellectual property rights, we may be forced to expend significant financial resources and management time litigating such
claims and our operating results could suffer.


 


Third parties may claim that our products
and systems infringe upon third-party patents and other intellectual property rights. These parties could bring legal actions against
us claiming damages and seeking to enjoin manufacturing and marketing of our products for allegedly conflicting with patents held
by them.


 


Identifying third-party patent rights can
be particularly difficult, notably because patent applications are generally not published until up to 18 months after their filing
dates. If a competitor were to challenge our patents, or assert that our products or processes infringe their patent or other intellectual
property rights, we could incur substantial litigation costs, be forced to make expensive product modifications, pay substantial
damages or even be forced to cease some operations. If any such actions are successful, in addition to any potential liability
for damages, we could be required to obtain a license in order to continue to manufacture or market the affected products. There
can be no assurance that we would prevail in any such action or that any license required under any such patent would be made available
on acceptable terms, if at all. Failure to obtain needed patents, licenses or proprietary information held by others may have a
material adverse effect on our business.


 


Third-party infringement claims, regardless
of their outcome, would not only drain financial resources but also divert the time and effort of management and could result in
customers or potential customers deferring or limiting their purchase or use of the affected products or services until resolution
of the litigation.


 


The disruption or loss of relationships with vendors and
suppliers for the components of our products could materially adversely affect our business.


 


Our ability to manufacture and market our
products successfully is dependent on relationships with both third party vendors and suppliers. We rely on various vendors and
suppliers for the components of our products and procure these components through purchase orders, with no guaranteed supply arrangements.
Certain components are only available from a limited number of suppliers.


 






    	 



    	 



    

 


Our inability to obtain sufficient quantities
of these components, if and as required in the future, may subject us to:


 


	 	•	
        delays in delivery or shortages in components that could interrupt
        and delay manufacturing and result in cancellations of orders for our products;

         

	 	•	increased component prices and supply delays as we establish alternative suppliers;
	 	•	
        inability to develop alternative sources for product components

        ;

	 	•	
        required modifications of our products, which may cause delays
        in product shipments, increased manufacturing costs, and increased product prices; and

         

	 	•	
        increased inventory costs as we hold more inventory than we
        otherwise might in order to avoid problems from shortages or discontinuance, which may result in write-offs if we are unable to
        use all such products in the future.

         



The loss of any significant supplier, in the absence of a timely
and satisfactory alternative arrangement, or an inability to obtain essential components on reasonable terms or at all, could materially
adversely affect our business, operations and cash flows.


 


Loss of any of our executive officers or key employees
and our failure to attract and retain qualified personnel, will harm the ability of the business to grow.


 


Our success depends, in part, on our ability
to retain current key personnel, attract and retain future key personnel, additional qualified management, marketing, scientific,
and engineering personnel, and develop and maintain relationships with other outside consultants. Competition for qualified management,
technical, sales and marketing employees is intense. In addition, some employees might leave our company and go to work for competitors.


 


If we lose any of our executive officers
or key employees, including Joseph E. Gonnella, Louis S. Camilli and Bryan C. Templeton, which have many years of experience with
us and within the automotive industry and other manufacturing industries, or are unable to recruit qualified personnel, our ability
to manage the day-to-day aspects of our business may be materially adversely affected. We do not currently maintain “key
person” life insurance on any of our executives or employees. Our senior management and key personnel are all employed on
an at-will basis, which means that they could terminate their employment with us at any time, for any reason and without notice.
The loss of the services of one or more executive officers or key employees, who also have strong personal ties with our customers
and suppliers, could have a material adverse effect on the our business, financial condition and results of operations.


 


Our operations are subject to hazards that may cause personal
injury or property damage, thereby subjecting us to liabilities and possible losses, which may not be covered by insurance.


 


Our workers are subject to hazards associated
with developing, manufacturing and testing our products. In such a case, we may be liable for fines and damages. These operating
hazards can cause personal injury and loss of life, damage to or destruction of property, plant and equipment and environmental
damage. Even though we believe that the insurance coverage we maintain is in amounts and against the risks that we believe are
consistent with industry practice, this insurance may not be adequate to cover all losses or liabilities that we may incur in our
operations. To the extent that we experience a material increase in the frequency or severity of accidents or workers’ compensation
claims, or unfavorable developments on existing claims, our business, financial condition, results of operations and prospects
could be adversely affected.


 


The Occupational Safety and Health Act of
1970, as amended, or OSHA, establishes certain employer responsibilities, including the maintenance of a workplace free of recognized
hazards likely to cause death or serious injury, compliance with standards promulgated by the Occupational Health and Safety and
Health Administration and various recordkeeping, disclosure and procedural requirements. While we have invested, and will continue
to invest, substantial resources in occupational health and safety programs, serious accidents or violations of OSHA rules may
subject us to substantial penalties, civil litigation or criminal prosecution, which could adversely affect our business, financial
condition, results of operations and prospects.


 






    	 



    	 



    

 


Any liability for damages resulting from technical faults
or failures of our products could be substantial and could materially adversely affect our business and results of operations.


 


Our products are integrated into goods used
by consumers and therefore a malfunction or the inadequate design of our products could result in product liability claims. Any
liability for damages resulting from technical faults or failures could be substantial and could materially adversely affect our
business and results of operations. In addition, a well-publicized actual or perceived problem could adversely affect the market’s
perception of our products, which would materially impact our financial condition and operating results.


 


A significant product liability lawsuit, warranty claim
or product recall involving us or one of our major customers could adversely affect our financial performance.


 


In the event that our products fail to perform
as expected, whether allegedly due to our fault, and such failure results in, or is alleged to result in, bodily injury and/or
property damage or other losses, we may be subject to product liability lawsuits and other claims. If available, product liability
insurance generally is expensive. While we presently have product liability coverage at amounts we currently consider adequate,
there can be no assurance that we will be able to obtain or maintain such insurance on acceptable terms with respect to other products
we may develop, or that any insurance will provide adequate protection against any potential liabilities. In the event of a successful
claim against us, a lack or insufficiency of insurance coverage could have a material adverse effect on our business and operations.
These types of claims could adversely affect our financial condition, operating results and cash flows.


 


We may not have sufficient cash to satisfy our redemption
obligations with respect to the shares of our common stock owned by Gordian Group and may need to obtain additional debt or equity
financing in order to satisfy such obligations.


 


On October 21, 2013 we granted Gordian Group,
LLC, or Gordian, a contractual right to require us to redeem all of their shares of our common stock (131,287 shares) at any time
on or after May 24, 2014. Upon any such redemption request by Gordian, we will be required to make an aggregate cash payment equal
to the greater of (a) $300,000 and (b) the fair market value of our common stock at the time of our receipt of Gordian’s
redemption request. We have a limited amount of revenues and a history of losses, and we may not have sufficient cash to allow
us to comply with our redemption obligations. We may need to obtain additional debt or equity financing in order to satisfy any
redemption requirement, which financing may not be available on favorable terms or at all. If we are unable to meet any redemption
request by Gordian, we may be subject to time-consuming and costly claims or legal proceedings.


 


As an “emerging growth company” under the
JOBS Act, we are permitted to rely on exemptions from certain disclosure requirements.


 


We qualify as an “emerging growth company”
under the JOBS Act. As a result, we are permitted to and may rely on exemptions from certain disclosure requirements. For so long
as we are an emerging growth company, we will not be required to:


 


	 	•	
        have an auditor report on our internal controls over financial
        reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act;

         

	 	•	
        comply with any requirement that may be adopted by the Public
        Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing
        additional information about the audit and the financial statements (i.e., an auditor discussion and analysis);

         

	 	•	
        submit certain executive compensation matters to shareholder
        advisory votes, such as “say-on-pay”, “say-on-frequency” and “say-on-golden parachute;” and

         

	 	•	disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the Chief Executive’s compensation to median employee compensation.


 






    	 



    	 



    

 


In addition, Section 107 of the JOBS Act
also provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B)
of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay
the adoption of certain accounting standards until those standards would otherwise apply to private companies. We are choosing
to “opt out” of this provision and, as a result, we will comply with new or revised accounting standards as required
when they are adopted. Section 107 of the JOBS Act provides that our decision to opt out of the extended transition period for
complying with new or revised accounting standards is irrevocable.


 


We will remain an “emerging growth
company” until the last day of our fiscal year following the fifth anniversary of the date of our first sale of common equity
securities pursuant to an effective registration under the Securities Act, or until the earliest of (i) the last day of the first
fiscal year in which our total annual gross revenues exceed $1 billion, (ii) the date that we become a “large accelerated
filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, which would occur if the market value of our ordinary
shares that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal
quarter or (iii) the date on which we have issued more than $1 billion in non-convertible debt during the preceding three year
period.


 


Until such time, however, we cannot predict
if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common
stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more
volatile.


 


Risks Related to Our Industry


 


The adoption cycle for our automotive products is lengthy
and the lengthy cycle impedes growth in our sales.


 


The adoption cycle in the automotive components
industry can be as long as four years or more for products that must be designed into a new vehicle or engine platform, because
some companies take that long to design and develop a new vehicle or engine platform. Even when selling parts that are neither
safety-critical nor highly integrated into the vehicle, there are still many stages that an automotive supply company must go through
before achieving commercial sales. The sales cycle is lengthy because an automobile manufacturer must develop a high degree of
assurance that the products it buys will meet customer needs, interface as easily as possible with the other parts of a vehicle
and with the automobile manufacturer’s production and assembly process, and have minimal warranty, safety and service problems.
As a result, from the time that a manufacturer develops a strong interest in our products, it normally will take several years
before our products are available to consumers in that manufacturer’s vehicles.


 


In the automotive components industry, products
typically proceed through five stages of research and development. Initial research on the product concept comes first, to assess
its technical feasibility and economic costs and benefits. This stage often includes development of an internal prototype for the
component supplier’s own evaluation. If the product appears feasible, the component supplier manufactures a functioning prototype
to demonstrate and test the product’s features. These prototypes are then marketed and sold to automotive companies for testing
and evaluation. If an automobile manufacturer shows interest in the product, it typically works with the component supplier to
refine the product, then purchases second and subsequent generation engineering prototypes for further evaluation. Finally, the
automobile manufacturer either decides to purchase the component for a production vehicle or terminates the program.


 


The time required to progress through these
five stages to commercialization varies widely. Generally, the more a component must be integrated with other vehicle systems,
the longer the process takes. Further, products that are installed by the factory usually require extra time for evaluation because
other vehicle systems are affected, and a decision to introduce the product into the vehicle is not easily reversed. Because
our products are a factory-installed item, the process may take a significant amount of time to commercialization.


 






    	 



    	 



    

 


Other pulse plug products that we develop
are also likely to have a lengthy sales cycle. Because such technology is new and evolving, and because customers will likely require
that any new product we develop pass certain feasibility and economic viability tests before committing to purchase, it is expected
that any new products we develop will take some years before they are sold to automotive customers.


 


The automotive industry is subject to intense competition
and our current automotive products may be rendered obsolete by future technological developments in the industry.


 


We operate in an extremely competitive industry,
driven by global vehicle production volumes and part replacement trends. Business is typically awarded to the supplier offering
the most favorable combination of cost, quality, technology and service. Many of our competitors are substantially larger in size
and have substantially greater financial, marketing and other resources than we do. Some of our competitors have already achieved
greater market penetration than we have in the markets in which we compete, and some have greater financial and other resources
than we do. A number of national companies in our industry are larger than we are and, if they so desire, could establish a presence
in our markets and compete with us for contracts. As a result of this competition, we may need to accept lower contract margins
in order to compete against competitors that have the ability to accept awards at lower prices or have a pre-existing relationship
with a customer.


 


Competitors are promoting ignition systems
that may compete with our products. Competition extends to attracting and retaining qualified technical and marketing personnel.
There can be no assurance that we will successfully differentiate our products from those of our competitors, that the marketplace
will consider our current or proposed products to be superior or even comparable to those of our competitors, or that we can succeed
in establishing new or maintaining existing relationships with automobile manufacturers. Furthermore, no assurance can be given
that competitive pressures we face will not adversely affect our financial performance.


 


Due to the rapid pace of technological change,
as with any technology-based product, our products may even be rendered obsolete by future developments in the industry. Our competitive
position would be adversely affected if we were unable to anticipate such future developments and obtain access to the new technology.


 


Adverse conditions in the automotive market may adversely
affect future demand for our products.


 


Part of our revenues is tied to global OEM
automobile sales, production levels, and independent aftermarket parts replacement activity. The OEM market is characterized by
short-term volatility, with overall expected long-term growth in global vehicle sales and production. Automotive production in
the local markets we serve can be affected by macro-economic factors such as interest rates, fuel prices, consumer confidence,
employment trends, regulatory and legislative oversight requirements and trade agreements. A variation in the level of automobile
production would affect not only our expected future sales to OEM customers but, depending on the reasons for the change, could
impact demand from aftermarket customers. Our results of operations and financial condition could be adversely affected if we fail
to respond in a timely and appropriate manner to changes in the demand for our products.


 


We may become subject to pricing pressure from our automotive
OEM customers, which could adversely affect our earnings.


 


There is substantial and continuing pressure
from automotive OEMs to reduce the prices they pay to suppliers. Virtually all OEMs have aggressive price reduction initiatives
that they impose upon their suppliers, and such actions are expected to continue in the future. Since suppliers' prices cannot
increase, suppliers must be able to reduce their operating costs in order to maintain profitability.


 


To the extent we are successful in expanding
our business to provide products to automotive OEMs, we will be subject to this pricing pressure from the OEMs. If we are unable
to offset customer price reductions that may be required by the automotive OEMs through improved operating efficiencies, new manufacturing
processes, sourcing alternatives, technology enhancements and other cost reduction initiatives, our results of operations and financial
condition would be adversely affected.


 






    	 



    	 



    

 


Because many of the largest automotive manufacturers are
located in foreign countries, our business may be subject to the risks associated with foreign sales.


 


Many of the world’s largest automotive manufacturers are
located in foreign countries. Accordingly, if these automotive OEMs become our customers our business may be subject to many of
the risks of international operations, including governmental controls, tariff restrictions, foreign currency fluctuations and
currency control regulations. No assurance can be given that future contracts will be honored by our foreign suppliers or customers.


 




    	 



    	 



    

 


EXHIBIT A


 


FORM OF PROMISSORY NOTE


 


(attached)


 




    	 



    	 



    

 


EXHIBIT B


 


FORM OF SECURITY AGREEMENT


 


(attached)